Unit 701-706
K11 Atelier King’s Road 728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com
Sector(es): Healthcare
Industria: Diagnostics & Research
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Sheng Wu Yeung | Co-Founder, Chairperson & CEO | N/D | N/D | 1979 |
Dr. Chi Hung Tzang Ph.D. | Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board | N/D | N/D | 1975 |
Mr. Hoi Chun Lo | Chief Financial Officer | N/D | N/D | 1985 |
Dr. Yung Ho Wong DPHIL | Chief Technology Officer | N/D | N/D | 1982 |
Ms. Samantha Kwok | Chief of Staff to Group CEO & Vice President, People & Operations | N/D | N/D | N/D |
Dr. Senthil Sundaram M.D. | Chief Clinical Officer | N/D | N/D | 1974 |
Mr. Joel Neoh | Chief Consumer Officer & Chief Executive Officer for CircleDNA | N/D | N/D | 1984 |
Mr. Walt Ling | Chief Executive Officer of ACT Genomics | N/D | N/D | N/D |
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
La calificación ISS Governance QuickScore de Prenetics Global Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.